FIGURE 1.
Survival curves of progression‐free survival (PFS) between extensive stage small‐cell lung cancer (ES‐SCLC) patients who chose immunotherapy combined with chemotherapy and chemotherapy as the first‐line (FL) treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.